SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-554317
Filing Date
2016-04-25
Accepted
2016-04-25 17:05:10
Documents
7
Period of Report
2016-06-14
Effectiveness Date
2016-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d147794ddef14a.htm DEF 14A 635477
2 GRAPHIC g147794g46y86.jpg GRAPHIC 7878
3 GRAPHIC g147794pc_pg001a.jpg GRAPHIC 44335
4 GRAPHIC g147794pc_pg001b.jpg GRAPHIC 39056
5 GRAPHIC g147794pc_pg001c.jpg GRAPHIC 7271
6 GRAPHIC g147794pc_pg001d.jpg GRAPHIC 14581
7 GRAPHIC g147794pc_pg001e.jpg GRAPHIC 38261
  Complete submission text file 0001193125-16-554317.txt   845925
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30171 | Film No.: 161589616
SIC: 2836 Biological Products, (No Diagnostic Substances)